Literature DB >> 8968501

Multiplicity within cyclic nucleotide phosphodiesterases.

S D Rybalkin1, J A Beavo.   

Abstract

Mesh:

Substances:

Year:  1996        PMID: 8968501     DOI: 10.1042/bst0241005

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


× No keyword cloud information.
  4 in total

1.  Topical combinations to treat microvascular dysfunction of chronic postischemia pain.

Authors:  André Laferrière; Rachid Abaji; Cheng-Yu Mark Tsai; J Vaigunda Ragavendran; Terence J Coderre
Journal:  Anesth Analg       Date:  2014-04       Impact factor: 5.108

2.  Topical combinations aimed at treating microvascular dysfunction reduce allodynia in rat models of CRPS-I and neuropathic pain.

Authors:  J Vaigunda Ragavendran; André Laferrière; Wen Hua Xiao; Gary J Bennett; Satyanarayana S V Padi; Ji Zhang; Terence J Coderre
Journal:  J Pain       Date:  2013-01       Impact factor: 5.820

3.  Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory.

Authors:  M Barad; R Bourtchouladze; D G Winder; H Golan; E Kandel
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

4.  Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1C) is induced in human arterial smooth muscle cells of the synthetic, proliferative phenotype.

Authors:  S D Rybalkin; K E Bornfeldt; W K Sonnenburg; I G Rybalkina; K S Kwak; K Hanson; E G Krebs; J A Beavo
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.